Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by dooneryon Nov 11, 2015 8:44am

88 Views

Post# 24280311

RE:You notice something different this time

,,,GREAT,post Tickle,,,TIMING,,,few months,,and if you read my post of nov 4,,,,FOCUS,,.."IMMEDIATE,efforts towards towards closing a major transaction for our newest skin lightner"Seems to me a deal on skin lightner is on the way within a few months,and while this plays out Mason gets deal #2 ready.Then theres door number 3 in the wings.Seems to me they have layed the plan out,we just have to read about it,beleive,and wait and not worry about the day to day prices cause they have no bearing on the potential prices we could see.GLTA,,,

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario